XML 168 R144.htm IDEA: XBRL DOCUMENT v3.25.3
FAIR VALUE MEASUREMENT - Valuation Techniques and Inputs for Level 3 Nonrecurring Fair Value Measurements (Details)
3 Months Ended 9 Months Ended
Sep. 30, 2025
USD ($)
decimal
Sep. 30, 2024
USD ($)
Sep. 30, 2025
USD ($)
decimal
Sep. 30, 2024
USD ($)
Dec. 31, 2024
USD ($)
decimal
Nonrecurring          
Nonrecurring fair value changes included in earnings          
Nonrecurring fair value measurements included in earnings $ (98,000,000) $ (25,000,000) $ (141,000,000) $ (42,000,000)  
Nonrecurring | Level 3          
Valuation techniques and inputs          
Loans HFS 236,000,000   236,000,000   $ 271,000,000
Loans         353,000,000
Other real estate owned         19,000,000
Price-based | Level 3          
Valuation techniques and inputs          
Non-marketable equities 96,000,000   96,000,000   81,000,000
Price-based | Nonrecurring | Level 3          
Valuation techniques and inputs          
Non-marketable equities 163,000,000   163,000,000   136,000,000
Price-based | Nonrecurring | Level 3 | Minimum          
Valuation techniques and inputs          
Loans HFS $ 235,000,000   $ 235,000,000   $ 271,000,000
Price-based | Price | Level 3 | Minimum          
Valuation techniques and inputs          
Non-marketable equities 2.90   2.90   0.54
Price-based | Price | Level 3 | Maximum          
Valuation techniques and inputs          
Non-marketable equities 353.72   353.72   2,960.96
Price-based | Price | Level 3 | Weighted Average          
Valuation techniques and inputs          
Non-marketable equities 125.66   125.66   432.84
Price-based | Price | Nonrecurring | Level 3 | Minimum          
Valuation techniques and inputs          
Loans HFS 80.00   80.00   0
Non-marketable equities 9.94   9.94   1.50
Price-based | Price | Nonrecurring | Level 3 | Maximum          
Valuation techniques and inputs          
Loans HFS 100.00   100.00   101.00
Non-marketable equities 205.01   205.01   2,961
Price-based | Price | Nonrecurring | Level 3 | Weighted Average          
Valuation techniques and inputs          
Loans HFS 95.55   95.55   96.61
Non-marketable equities 94.50   94.50   258.00
Price-based | Measurement Input, Appraised Value [Member] | Nonrecurring | Level 3 | Minimum          
Valuation techniques and inputs          
Other real estate owned         503,332
Price-based | Measurement Input, Appraised Value [Member] | Nonrecurring | Level 3 | Maximum          
Valuation techniques and inputs          
Other real estate owned         7,220,000
Price-based | Measurement Input, Appraised Value [Member] | Nonrecurring | Level 3 | Weighted Average          
Valuation techniques and inputs          
Other real estate owned         4,309,976
Recovery analysis | Nonrecurring | Level 3          
Valuation techniques and inputs          
Loans $ 620,000,000   $ 620,000,000    
Recovery analysis | Measurement Input, Discounted Cash Flow | Nonrecurring | Level 3 | Minimum          
Valuation techniques and inputs          
Loans 10,000   10,000    
Recovery analysis | Measurement Input, Discounted Cash Flow | Nonrecurring | Level 3 | Maximum          
Valuation techniques and inputs          
Loans 184,687,798   184,687,798    
Recovery analysis | Measurement Input, Discounted Cash Flow | Nonrecurring | Level 3 | Weighted Average          
Valuation techniques and inputs          
Loans 99,270,639   99,270,639    
Recovery analysis | Measurement Input, Appraised Value [Member] | Nonrecurring | Level 3 | Minimum          
Valuation techniques and inputs          
Loans         10,000
Recovery analysis | Measurement Input, Appraised Value [Member] | Nonrecurring | Level 3 | Maximum          
Valuation techniques and inputs          
Loans         104,049,422
Recovery analysis | Measurement Input, Appraised Value [Member] | Nonrecurring | Level 3 | Weighted Average          
Valuation techniques and inputs          
Loans         58,636,070
Recovery analysis | Recovery rate | Nonrecurring | Level 3 | Minimum          
Valuation techniques and inputs          
Loans 0.3510   0.3510    
Recovery analysis | Recovery rate | Nonrecurring | Level 3 | Maximum          
Valuation techniques and inputs          
Loans 0.9010   0.9010    
Recovery analysis | Recovery rate | Nonrecurring | Level 3 | Weighted Average          
Valuation techniques and inputs          
Loans 0.5797   0.5797    
Comparable analysis | Nonrecurring | Level 3          
Valuation techniques and inputs          
Non-marketable equities $ 127,000,000   $ 127,000,000    
Comparable analysis | Revenue multiple | Nonrecurring | Level 3 | Minimum          
Valuation techniques and inputs          
Non-marketable equities | decimal 3.00   3.00   3.80
Comparable analysis | Revenue multiple | Nonrecurring | Level 3 | Maximum          
Valuation techniques and inputs          
Non-marketable equities | decimal 53.75   53.75   9.19
Comparable analysis | Revenue multiple | Nonrecurring | Level 3 | Weighted Average          
Valuation techniques and inputs          
Non-marketable equities | decimal 31.84   31.84   6.67
Comparable analysis | Level 3          
Valuation techniques and inputs          
Non-marketable equities $ 277,000,000   $ 277,000,000   $ 222,000,000
Comparable analysis | Nonrecurring | Level 3          
Valuation techniques and inputs          
Non-marketable equities         $ 29,000,000
Comparable analysis | Revenue multiple | Level 3 | Minimum          
Valuation techniques and inputs          
Non-marketable equities | decimal 8.61   8.61   4.50
Comparable analysis | Revenue multiple | Level 3 | Maximum          
Valuation techniques and inputs          
Non-marketable equities | decimal 30.71   30.71   16.31
Comparable analysis | Revenue multiple | Level 3 | Weighted Average          
Valuation techniques and inputs          
Non-marketable equities | decimal 14.10   14.10   11.97
Loans held-for-sale | Nonrecurring          
Nonrecurring fair value changes included in earnings          
Nonrecurring fair value measurements included in earnings $ (10,000,000) (1,000,000) $ (22,000,000) (46,000,000)  
Other real estate owned | Nonrecurring          
Nonrecurring fair value changes included in earnings          
Nonrecurring fair value measurements included in earnings (1,000,000) 0 (1,000,000) 0  
Loans | Nonrecurring          
Nonrecurring fair value changes included in earnings          
Nonrecurring fair value measurements included in earnings (79,000,000) (16,000,000) (67,000,000) (16,000,000)  
Non-marketable equity securities | Nonrecurring          
Nonrecurring fair value changes included in earnings          
Nonrecurring fair value measurements included in earnings $ (8,000,000) $ (8,000,000) $ (51,000,000) $ 20,000,000